Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1995 2
1997 2
1998 3
1999 1
2000 8
2001 13
2002 4
2003 8
2004 4
2005 3
2006 10
2007 10
2008 8
2009 9
2010 22
2011 29
2012 30
2013 32
2014 27
2015 33
2016 37
2017 70
2018 65
2019 65
2020 69
2021 49
2022 57
2023 17
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21047883

616 results

Results by year

Filters applied: . Clear all
Page 1
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
Mulugeta E, Londos E, Ballard C, Alves G, Zetterberg H, Blennow K, Skogseth R, Minthon L, Aarsland D. Mulugeta E, et al. J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):160-4. doi: 10.1136/jnnp.2009.199398. Epub 2010 Nov 3. J Neurol Neurosurg Psychiatry. 2011. PMID: 21047883
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.
van Steenoven I, Aarsland D, Weintraub D, Londos E, Blanc F, van der Flier WM, Teunissen CE, Mollenhauer B, Fladby T, Kramberger MG, Bonanni L, Lemstra AW; European DLB consortium. van Steenoven I, et al. J Alzheimers Dis. 2016 Aug 18;54(1):287-95. doi: 10.3233/JAD-160322. J Alzheimers Dis. 2016. PMID: 27567832 Free PMC article.
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L. Chiasserini D, et al. Alzheimers Res Ther. 2017 Jul 28;9(1):52. doi: 10.1186/s13195-017-0276-4. Alzheimers Res Ther. 2017. PMID: 28750675 Free PMC article.
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
Bousiges O, Bombois S, Schraen S, Wallon D, Quillard MM, Gabelle A, Lehmann S, Paquet C, Amar-Bouaziz E, Magnin E, Miguet-Alfonsi C, Delbeuck X, Lavaux T, Anthony P, Philippi N, Blanc F; ePLM network and collaborators. Bousiges O, et al. J Neurol Neurosurg Psychiatry. 2018 May;89(5):467-475. doi: 10.1136/jnnp-2017-316385. Epub 2018 Jan 10. J Neurol Neurosurg Psychiatry. 2018. PMID: 29321140
616 results